{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:37:59Z","timestamp":1785332279924,"version":"3.55.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jhltonline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.healun.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T23:34:13Z","timestamp":1497310453000},"page":"1155-1163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["von Willebrand factor disruption and continuous-flow circulatory devices"],"prefix":"10.1016","volume":"36","author":[{"given":"Alastair G.","family":"Proudfoot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Strueber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2017.06.004_bib1","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.06.004_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healun.2013.10.017","article-title":"Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation","volume":"33","author":"Grady","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.06.004_bib3","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jacc.2014.01.053","article-title":"Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support)","volume":"63","author":"Jorde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2017.06.004_bib4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2015.07.075","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP Study","volume":"66","author":"Estep","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2017.06.004_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.healun.2017.06.004_bib6","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2009.02.048","article-title":"Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II)","volume":"53","author":"Klovaite","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2017.06.004_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MAT.0b013e3181e5de0a","article-title":"Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients","volume":"56","author":"Crow","year":"2010","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2017.06.004_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCHEARTFAILURE.109.877597","article-title":"Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device","volume":"3","author":"Meyer","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2017.06.004_bib9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2017.06.004_bib10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/01.CIR.102.11.1290","article-title":"Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis","volume":"102","author":"Pareti","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.06.004_bib11","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMcibr1205363","article-title":"From clinical observation to mechanism\u2014Heyde\u2019s syndrome","volume":"367","author":"Loscalzo","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.06.004_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.athoracsur.2008.10.027","article-title":"Platelet dysfunction in outpatients with left ventricular assist devices","volume":"87","author":"Steinlechner","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ejcts\/ezu510","article-title":"Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices","volume":"48","author":"Baghai","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib14","first-page":"849","article-title":"Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device","volume":"30","author":"Demirozu","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.06.004_bib15","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device","volume":"23","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev-fluid-010814-014513","article-title":"Fluid mechanics of blood clot formation","volume":"47","author":"Fogelson","year":"2015","journal-title":"Annu Rev Fluid Mech"},{"key":"10.1016\/j.healun.2017.06.004_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0021-9290(77)90006-9","article-title":"Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man","volume":"10","author":"Back","year":"1977","journal-title":"J Biomech"},{"key":"10.1016\/j.healun.2017.06.004_bib18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/279636a0","article-title":"Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium","volume":"279","author":"Sakariassen","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.healun.2017.06.004_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0092-8674(00)81607-4","article-title":"Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow","volume":"94","author":"Savage","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.healun.2017.06.004_bib20","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V96.10.3322","article-title":"Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins","volume":"96","author":"Andre","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jcp.27.7.517","article-title":"The structure and growth of valve-pocket thrombi in femoral veins","volume":"27","author":"Sevitt","year":"1974","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.healun.2017.06.004_bib22","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1073\/pnas.82.24.8752","article-title":"Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs","volume":"82","author":"Brinkhous","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2017.06.004_bib23","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1182\/blood-2008-10-165621","article-title":"Von Willebrand factor to the rescue","volume":"113","author":"De Meyer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s002770050184","article-title":"Von Willebrand factor: molecular size and functional activity","volume":"72","author":"Furlan","year":"1996","journal-title":"Ann Hematol"},{"key":"10.1016\/j.healun.2017.06.004_bib25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1083\/jcb.95.2.632","article-title":"Electron microscopy of human factor VIII\/Von Willebrand glycoprotein: effect of reducing reagents on structure and function","volume":"95","author":"Ohmori","year":"1982","journal-title":"J Cell Biol"},{"key":"10.1016\/j.healun.2017.06.004_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2006-947866","article-title":"Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.healun.2017.06.004_bib27","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1182\/blood.V70.1.173.173","article-title":"Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals","volume":"70","author":"Batlle","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib29","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib30","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.0801735105","article-title":"Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13","volume":"105","author":"Cao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2017.06.004_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2007-05-093021","article-title":"Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress","volume":"111","author":"Shim","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib32","doi-asserted-by":"crossref","first-page":"28596","DOI":"10.1074\/jbc.M110.131227","article-title":"Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress","volume":"285","author":"Skipwith","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.healun.2017.06.004_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ncomms1385","article-title":"Calcium modulates force sensing by the von Willebrand factor A2 domain","volume":"2","author":"Jakobi","year":"2011","journal-title":"Nature Comm"},{"key":"10.1016\/j.healun.2017.06.004_bib34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jth.13551","article-title":"Von Willebrand factor and angiogenesis: basic and applied issues","volume":"15","author":"Randi","year":"2017","journal-title":"J Thromb Hemost"},{"key":"10.1016\/j.healun.2017.06.004_bib36","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood"},{"issue":"Suppl 2","key":"10.1016\/j.healun.2017.06.004_bib37","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0049-3848(13)70003-3","article-title":"Diagnosis and treatment of acquired von Willebrand syndrome","volume":"130","author":"Tiede","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.healun.2017.06.004_bib38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0003-4975(10)62112-1","article-title":"The association of unexplained gastrointestinal bleeding with calcific aortic stenosis","volume":"44","author":"King","year":"1987","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2169\/internalmedicine.46.6026","article-title":"Occult gastrointestinal bleeding due to acquired von Willebrand syndrome in a patient with hypertrophic obstructive cardiomyopathy","volume":"46","author":"Shimizu","year":"2007","journal-title":"Int Med"},{"key":"10.1016\/j.healun.2017.06.004_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJM195807242590416","article-title":"G.astrointestinal bleeding in aortic stenosis.","volume":"259","author":"Heyde","year":"1958","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.06.004_bib41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/gast.2001.21204","article-title":"Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract","volume":"120","author":"Veyradier","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.healun.2017.06.004_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijcard.2006.08.078","article-title":"Severe aortic valve stenosis and nosebleed","volume":"120","author":"Schodel","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2017.06.004_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0140-6736(92)92434-H","article-title":"Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand\u2019s disease the link?","volume":"340","author":"Warkentin","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2017.06.004_bib44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.06.004_bib45","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.athoracsur.2005.07.074","article-title":"Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis","volume":"81","author":"Yoshida","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtcvs.2011.05.034","article-title":"Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome","volume":"144","author":"Thompson","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cjca.2015.01.012","article-title":"Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor","volume":"31","author":"Caspar","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.healun.2017.06.004_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4065\/mcp.2010.0309","article-title":"Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy","volume":"86","author":"Blackshear","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.healun.2017.06.004_bib49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jth.12780","article-title":"Remission of recurrent gastrointestinal bleeding after septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy-associated acquired von Willebrand syndrome","volume":"13","author":"Blackshear","year":"2015","journal-title":"J Thromb Hemost"},{"key":"10.1016\/j.healun.2017.06.004_bib50","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjcard.2012.10.015","article-title":"Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study)","volume":"111","author":"Blackshear","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2017.06.004_bib51","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2015.02.008","article-title":"Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement","volume":"8","author":"Spangenberg","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.healun.2017.06.004_bib52","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/CIRCRESAHA.116.305046","article-title":"von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions","volume":"116","author":"Van Belle","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.06.004_bib53","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2006-04-011551","article-title":"Activation-independent platelet adhesion and aggregation under elevated shear stress","volume":"108","author":"Ruggeri","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib54","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1073\/pnas.0608422104","article-title":"Shear-induced unfolding triggers adhesion of von Willebrand factor fibers","volume":"104","author":"Schneider","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2017.06.004_bib55","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1182\/blood-2007-04-083329","article-title":"The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib56","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/j.1538-7836.2009.03620.x","article-title":"Multi-step binding of ADAMTS-13 to von Willebrand factor","volume":"7","author":"Feys","year":"2009","journal-title":"J Thromb Hemost"},{"key":"10.1016\/j.healun.2017.06.004_bib57","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2009-05-224915","article-title":"A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF","volume":"114","author":"Zanardelli","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib58","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1170905","article-title":"Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor","volume":"324","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.healun.2017.06.004_bib59","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.0903679106","article-title":"Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.healun.2017.06.004_bib60","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib61","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.bpj.2008.12.3900","article-title":"Fluid shear induces conformation change in human blood protein von Willebrand factor in solution","volume":"96","author":"Singh","year":"2009","journal-title":"Biophys J"},{"key":"10.1016\/j.healun.2017.06.004_bib62","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bpj.2015.12.023","article-title":"Shear-induced unfolding and enzymatic cleavage of full-length VWF multimers","volume":"110","author":"Lippok","year":"2016","journal-title":"Biophys J"},{"key":"10.1016\/j.healun.2017.06.004_bib63","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jmb.2006.10.067","article-title":"Conformational stability and domain unfolding of the Von Willebrand factor A domains","volume":"366","author":"Auton","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.healun.2017.06.004_bib64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtcvs.2014.09.031","article-title":"Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage","volume":"149","author":"Bartoli","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib65","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1182\/blood-2009-07-231597","article-title":"Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage","volume":"114","author":"Turner","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib66","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2005-04-1758","article-title":"Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis","volume":"107","author":"Hassenpflug","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0079-6107(02)00052-4","article-title":"Fluid shear stress and the vascular endothelium: for better and for worse","volume":"81","author":"Resnick","year":"2003","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.healun.2017.06.004_bib68","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jtcvs.2007.05.024","article-title":"Three-dimensional magnetic resonance flow analysis in a ventricular assist device","volume":"134","author":"Markl","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib69","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1525-1594.2007.00421.x","article-title":"Experimental study on shear stress distributions in a centrifugal blood pump","volume":"31","author":"Mizunuma","year":"2007","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2017.06.004_bib70","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1111\/j.1525-1594.2011.01416.x","article-title":"Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device","volume":"36","author":"Selgrade","year":"2012","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2017.06.004_bib71","doi-asserted-by":"crossref","first-page":"081002","DOI":"10.1115\/1.4007092","article-title":"A quantitative comparison of mechanical blood damage parameters in rotary ventricular assist devices: shear stress, exposure time and hemolysis index","volume":"134","author":"Fraser","year":"2012","journal-title":"J Biomech Eng"},{"key":"10.1016\/j.healun.2017.06.004_bib72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchf.2013.10.008","article-title":"Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device","volume":"2","author":"Meyer","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2017.06.004_bib73","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MAT.0000000000000157","article-title":"Immediate recovery of acquired von Willebrand syndrome after left ventricular assist device explantation: implications for heart transplantation","volume":"61","author":"Davis","year":"2015","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2017.06.004_bib74","first-page":"1328","article-title":"Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients","volume":"40","author":"Heilmann","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib75","doi-asserted-by":"crossref","unstructured":"Kang J, Zhang DM, Restle DJ, et al. Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation. J Thorac Cardiovasc Surg 201;151:1747-54.","DOI":"10.1016\/j.jtcvs.2016.01.031"},{"key":"10.1016\/j.healun.2017.06.004_bib76","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.healun.2016.05.019","article-title":"Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure","volume":"35","author":"Netuka","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.06.004_bib77","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.thromres.2015.11.002","article-title":"Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent","volume":"137","author":"Jilma-Stohlawetz","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.healun.2017.06.004_bib78","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.ATV.0000201931.16535.e1","article-title":"Shear induces a unique series of morphological changes in translocating platelets: effects of morphology on translocation dynamics","volume":"26","author":"Maxwell","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2017.06.004_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2004-11-4188","article-title":"Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow","volume":"106","author":"Tao","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib80","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-06-2096","article-title":"Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin","volume":"105","author":"Studt","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib81","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2015-09-667642","article-title":"Free hemoglobin: a boost to platelet thrombi","volume":"126","author":"Jacquemin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib82","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1084\/jem.193.12.1341","article-title":"Control of von Willebrand factor multimer size by thrombospondin-1","volume":"193","author":"Xie","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.healun.2017.06.004_bib83","doi-asserted-by":"crossref","first-page":"21439","DOI":"10.1074\/jbc.M313560200","article-title":"Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice","volume":"279","author":"Pimanda","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.healun.2017.06.004_bib84","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/MCG.0000000000000260","article-title":"Expression of angiogenic factors in patients with sporadic small bowel angiodysplasia","volume":"49","author":"Holleran","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.healun.2017.06.004_bib85","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","article-title":"Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher non-surgical bleeding","volume":"134","author":"Tabit","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.06.004_bib86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0038-1647016","article-title":"Luminography\u2014an alternative assay for detection of von Willebrand factor multimers","volume":"60","author":"Schneppenheim","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.healun.2017.06.004_bib87","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0037-1615235","article-title":"Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome","volume":"80","author":"van Genderen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.healun.2017.06.004_bib88","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.healun.2013.02.006","article-title":"Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump","volume":"32","author":"Goda","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.06.004_bib89","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","article-title":"How I treat the acquired von Willebrand syndrome","volume":"117","author":"Tiede","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib90","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.healun.2015.06.018","article-title":"Safety of reduced anti-thrombotic strategies in HeartMate II patients: a one-year analysis of the US-TRACE Study","volume":"34","author":"Katz","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.06.004_bib91","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.healun.2017.06.004_bib92","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.healun.2017.06.004_bib93","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Hemost"},{"key":"10.1016\/j.healun.2017.06.004_bib94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.healun.2017.06.004_bib95","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2011.07.018","article-title":"Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation","volume":"141","author":"Ge","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.healun.2017.06.004_bib96","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2008.07005.x","article-title":"Von Willebrand disease and angiodysplasia responding to atorvastatin","volume":"142","author":"Sohal","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.healun.2017.06.004_bib97","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/MAT.0b013e318295232d","article-title":"Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?","volume":"59","author":"Rennyson","year":"2013","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2017.06.004_bib98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MAT.0000000000000143","article-title":"Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices","volume":"61","author":"Loyaga-Rendon","year":"2015","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2017.06.004_bib99","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1160\/TH14-02-0148","article-title":"Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices","volume":"112","author":"Rauch","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.healun.2017.06.004_bib100","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jchf.2015.06.016","article-title":"Inhibition of ADAMTS-13 by doxycycline reduces von Willebrand factor degradation during supraphysiological shear stress: therapeutic implications for left ventricular assist device-associated bleeding","volume":"3","author":"Bartoli","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2017.06.004_bib101","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jbiomech.2013.12.031","article-title":"Intraventricular flow patterns and stasis in the LVAD-assisted heart","volume":"47","author":"Wong","year":"2014","journal-title":"J Biomec"},{"key":"10.1016\/j.healun.2017.06.004_bib102","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jtcvs.2015.06.049","article-title":"High-speed visualization of disturbed pathlines in axial flow ventricular assist device under pulsatile conditions","volume":"150","author":"Yang","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib103","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCHEARTFAILURE.112.000206","article-title":"Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II","volume":"6","author":"Wever-Pinzon","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2017.06.004_bib104","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1525-1594.2010.01084.x","article-title":"Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience","volume":"34","author":"Hayes","year":"2010","journal-title":"Artif Organs"},{"key":"10.1016\/j.healun.2017.06.004_bib105","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jchf.2016.08.005","article-title":"Association of nasal mucosal vascular alterations, gastrointestinal arteriovenous malformations, and bleeding in patients with continuous-flow left ventricular assist devices","volume":"4","author":"Patel","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2017.06.004_bib106","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.2011.38.7621","article-title":"Targeting the angiopoietin\/Tie2 pathway: cutting tumor vessels with a double-edged sword?","volume":"30","author":"Cascone","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.healun.2017.06.004_bib107","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/thoraxjnl-2015-207461","article-title":"The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities","volume":"71","author":"Millar","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.healun.2017.06.004_bib108","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.healun.2016.12.016","article-title":"Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices","volume":"36","author":"Houston","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.06.004_bib109","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.athoracsur.2016.06.112","article-title":"Left ventricular assist device design reduces von Willebrand factor degradation: a comparative study between the HeartMate II and the EVAHEART left ventricular assist system","volume":"103","author":"Bartoli","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2017.06.004_bib110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324981731848X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324981731848X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T02:25:49Z","timestamp":1602296749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324981731848X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":110,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S105324981731848X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2017.06.004","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand factor disruption and continuous-flow circulatory devices","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of International Society for the Heart and Lung Transplantation","name":"copyright","label":"Copyright"}]}}